Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius medical care deutschland gmbh - germania - calciu chloridum - sol. perf. - 100mmol/l - alte solutii intravenoase solutii de electroliti

Moldavië - Roemeens - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

fresenius kabi deutschland gmbh - comprimate filmate

Europese Unie - Roemeens - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - pegfilgrastimuluila - neutropenie - imunostimulante, , factorilor de stimulare a coloniilor - reducere durata de neutropenie şi incidenţa de neutropenie febrilă la pacienţii adulţi trataţi cu chimioterapie citotoxică pentru malignitate (cu excepția cronice myeloid leucemie şi mielodisplazice sindroame).

Europese Unie - Roemeens - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - imunosupresoare - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

labesfal-laboratorios almiro s.a. - portugalia - granisetronum - sol. inj. - 1mg/ml - antiemetice antagonisti ai serotoninei (5ht-3)

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius medical care deutschland gmbh - germania - combinatii - sol. dial. perit. - preparate pentru dializa peritoneala solutii hipertone

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius medical care deutschland gmbh - germania - natrii citras - sol. perf. - 136mmol/l - solutii pentru hemodializa si hemofiltrare solutii pentru hemofiltrare

Roemenië - Roemeens - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fresenius kabi norge as - norvegia - combinatii (levodopum+carbidopum) - gel intestinal - 20mg/ml+5mg/ml - medicamente dopaminergice dopa si derivati